Repligen RGEN
NASDAQ RGEN
$167.60 -2.01 (-1.19%)
At close: Sep 4, 2026 · 4:00 PM EDT

Repligen (RGEN) EV to EBIT (2010 - 2026)

Repligen's (RGEN) quarterly EV to EBIT came in at 478.31 in Q2 2026, up 5.7% year-over-year from 452.5 in Q2 2025, and up 34.74% quarter-over-quarter from 354.99 in Q1 2026.

Analysis

Repligen (RGEN) EV to EBIT (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported EV to EBIT for 17 consecutive years, with 478.31 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to EBIT rose 5.7% year-over-year to 478.31 in Q2 2026; TTM through Jun 2026 was 103.47, a 139.26% increase from a year earlier, with the FY2025 full-year figure at 149.73, up 171.86% from the prior year.
  • EV to EBIT was 478.31 for Q2 2026 at Repligen, up from 354.99 in the prior quarter.
  • Over five years, EV to EBIT peaked at 2530.59 in Q1 2024 and troughed at 964.5 in Q3 2024.
  • A 5-year average of 555.88 and a median of 427.58 in 2025 frame the typical range for EV to EBIT.
  • Across the five-year window, EV to EBIT soared 842.3% in 2023 and tumbled 154.92% in 2024, its largest moves.
  • Over 5 years, EV to EBIT stood at 179.84 in 2022, then surged by 422.4% to 939.47 in 2023, then plunged by 121.34% to 200.44 in 2024, then surged by 330.64% to 462.29 in 2025, then climbed by 3.46% to 478.31 in 2026.
  • The last three EV to EBIT figures came in at 478.31 (Q2 2026), 354.99 (Q1 2026), and 462.29 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 226.93 Bn 222.99 Bn 8.34 Bn
2 Danaher 145.94 Bn 141.60 Bn 3.61 Bn
3 Agilent Technologies 42.55 Bn 40.79 Bn 1.04 Bn
4 Illumina 32.95 Bn 31.78 Bn 770.00 Mn
5 Revvity 14.53 Bn 13.51 Bn 416.87 Mn
6 Bio-Techne 11.31 Bn 11.04 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.34 Bn 8.72 Bn 345.80 Mn
8 Repligen 9.46 Bn 8.44 Bn 110.04 Mn
9 Bruker 8.91 Bn 8.73 Bn 416.00 Mn
10 10x Genomics 8.16 Bn 7.61 Bn 112.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 478.31
Mar 31, 2026 354.99
Dec 31, 2025 462.29
Sep 30, 2025 402.65
Jun 30, 2025 452.50
Mar 31, 2025 980.69
Dec 31, 2024 -200.44
Sep 30, 2024 -964.50
Jun 30, 2024 1,140.60
Mar 31, 2024 2,530.59
Dec 31, 2023 939.47
Sep 30, 2023 1,756.12
Jun 30, 2023 377.68
Mar 31, 2023 631.42
Dec 31, 2022 179.84
Sep 30, 2022 186.37
Jun 30, 2022 133.16
Mar 31, 2022 164.02
Dec 31, 2021 375.28
Sep 30, 2021 339.77